In vivo CRISPR screens identify dual functions of DNMT3A in mediating tumor immune evasion
Open Access
- 11 September 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Cancer immunotherapy has achieved remarkable clinical efficacy across multiple cancers but remains ineffective for most patients, and the mechanisms underlying resistance remain incompletely understood. Here, we perform in vivo CRISPR-Cas9 screens in female mice and identify DNA methyltransferase 3 A (DNMT3A) as a key driver of tumor immune evasion through both methyltransferase-dependent and -independent mechanisms. DNMT3A represses TNFRSF1A and TNFRSF1B expression, enabling tumor cells to evade TNFα-induced killing. Independently of its methyltransferase activity, DNMT3A interacts with NFYA to activate cholesterol biosynthesis, leading to zymosterol accumulation in tumor interstitial fluid. Zymosterol impairs SREBP2 cleavage and promotes HMGCR degradation in CD8⁺ T cells, thereby suppressing cholesterol biosynthesis and compromising their antitumor effector functions. Targeting DNMT3A with antisense oligonucleotides overcomes resistance to immune checkpoint blockade. Collectively, these findings establish DNMT3A as an integrated epigenetic and metabolic checkpoint in tumor immune evasion and a potential target for immunotherapy.Keywords
This publication has 68 references indexed in Scilit:
- Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPRGenome Biology, 2015
- Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor regionJournal of Controlled Release, 2015
- Phthalimide conjugation as a strategy for in vivo target protein degradationScience, 2015
- Depletion of regulatory T cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T cellsClinical and Experimental Immunology, 2015
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screensGenome Biology, 2014
- Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarraysBioinformatics, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Functions of DNA methylation: islands, start sites, gene bodies and beyondNature Reviews Genetics, 2012
- Epigenetic changes in tumor Fas levels determine immune escape and response to therapyCancer Cell, 2002